International Congress Munich 2014

Saturday, 06.09.2014 Sunday, 07.09.2014 Monday, 08.09.2014 Tuesday, 09.09.2014 Wednesday, 10.09.2014		Sponsored symposia: Boehringer Ingelheim Evening Symposium: "Identifying the unmet needs in asthma: Who, why and how many?" Bayer Expert Forum: “Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in Non-CF Bronchiectasis”

Citations should be made in the following way: Authors. Title. Eur Respir J 2014; 44: Suppl. 58, abstract number.

Understanding the benefit of current personalised medicine platforms

Symposium
Chairs: B. Jobst (Heidelberg, Germany), E. Quoix (Strasbourg, France)
Aims: The aim of this session is to explore the benefit of personalised medicine in lung cancer and to educate the audience regarding the different technologies that are currently available.

Download all media

The clinical benefit of personalised medicine in lung cancer N. Peled (Tel Aviv, Israel)
The real challenges in next generation sequencing for solid tumors Y. Altschuler (Jerusalem, Israel)
Liquid biopsy: are we there yet? K. Luecke (Potsdam, Germany)